Evaluation of coagulation status in dogs with naturally occurring canine hyperadrenocorticism
Authors:
- Kate E. CreevyKCKate E. Creevy
- Benjamin M. BrainardBBBenjamin M. Brainard
- 22 November 2011
- journal article
- research article
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 21 (6) , 625-632
Abstract
Objective: To determine whether or not there are differences in coagulation parameters (eg, thrombelastography [TEG], activated partial thromboplastin time [aPTT], prothrombin time [PT], and fibrinogen) among dogs with naturally occurring hyperadrenocorticism (HAC), dogs withHACundergoing medical management, and dogs withoutHAC.Design: Prospective, observational study.Setting: Veterinary teaching hospital.Animals: Forty‐six client‐owned dogs undergoing adrenal function testing.Interventions: None.Measurements and Main Results: Nine dogs were diagnosed withHACde novo, 19 dogs were presented for therapeutic monitoring of previously diagnosedHAC, and 18 dogs did not haveHAC. Variables compared between groups were age, body weight, platelet count, mean platelet volume, serum concentrations of cholesterol, triglycerides, antithrombin,PT, aPTT, fibrinogen, andTEGparameters (eg, alpha angle,R,K, and maximum amplitude [MA]). Dogs withHACand dogs treated forHAChad higher serum cholesterol than dogs withoutHAC(P< 0.05). All groups had meanMAgreater than the institutional reference interval. There was a weak, positive correlation between hematocrit andMAthat was independent of diagnosis (r2= 0.266,P= 0.004).Conclusions: The results of this study do not support the supposition that a significant difference exists in coagulation tendencies between dogs withHACprior to treatment, dogs withHACduring treatment, and dogs withoutHAC. This disagreement with the classically accepted notion thatHACleads to a hypercoagulable state could be due to a couple of possibilities. Namely, the link betweenHACand hypercoagulability may be relatively weak, or our findings may be the result of a typeIIerror either as a result of a small sample size or the use of coagulation assays that are insensitive to the effects ofHACon the hemostatic system.Keywords
This publication has 31 references indexed in Scilit:
- Thromboelastography results on citrated whole blood from clinically healthy cats depend on modes of activationActa Veterinaria Scandinavica, 2010
- Discard volume necessary for elimination of heparin flush effect on thromboelastographyBlood Coagulation & Fibrinolysis, 2010
- Thrombelastography in 26 healthy horses with and without activation by recombinant human tissue factorJournal of Veterinary Emergency and Critical Care, 2009
- Validation of human recombinant tissue factor–activated thromboelastography on citrated whole blood from clinically healthy dogsVeterinary Clinical Pathology, 2005
- Thromboelastography Maximum Amplitude Predicts Postoperative Thrombotic Complications Including Myocardial InfarctionAnesthesia & Analgesia, 2005
- Aortic and iliac thrombosis in six dogsJournal of Small Animal Practice, 2000
- The fibrinolytic potential in patients with Cushing??s diseaseBlood Coagulation & Fibrinolysis, 1992
- THROMBOEMBOLIC COMPLICATIONS IN CUSHING'S SYNDROMEClinical Endocrinology, 1983
- Hyperlipidemia and AtherosclerosisScience, 1976
- Thromboembolic Complications, Heparin Treatment and Increase in Coagulation Factors in Cushing's SyndromeActa Medica Scandinavica, 1976